Literature DB >> 29334044

Gene-environment interplay in the etiology of psychosis.

Alyson Zwicker1, Eileen M Denovan-Wright2, Rudolf Uher1.   

Abstract

Schizophrenia and other types of psychosis incur suffering, high health care costs and loss of human potential, due to the combination of early onset and poor response to treatment. Our ability to prevent or cure psychosis depends on knowledge of causal mechanisms. Molecular genetic studies show that thousands of common and rare variants contribute to the genetic risk for psychosis. Epidemiological studies have identified many environmental factors associated with increased risk of psychosis. However, no single genetic or environmental factor is sufficient to cause psychosis on its own. The risk of developing psychosis increases with the accumulation of many genetic risk variants and exposures to multiple adverse environmental factors. Additionally, the impact of environmental exposures likely depends on genetic factors, through gene-environment interactions. Only a few specific gene-environment combinations that lead to increased risk of psychosis have been identified to date. An example of replicable gene-environment interaction is a common polymorphism in the AKT1 gene that makes its carriers sensitive to developing psychosis with regular cannabis use. A synthesis of results from twin studies, molecular genetics, and epidemiological research outlines the many genetic and environmental factors contributing to psychosis. The interplay between these factors needs to be considered to draw a complete picture of etiology. To reach a more complete explanation of psychosis that can inform preventive strategies, future research should focus on longitudinal assessments of multiple environmental exposures within large, genotyped cohorts beginning early in life.

Entities:  

Keywords:  environmental risk factors; genetics; gene–environment interactions; psychosis; schizophrenia

Mesh:

Year:  2018        PMID: 29334044     DOI: 10.1017/S003329171700383X

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  18 in total

1.  Affective lability in offspring of parents with major depressive disorder, bipolar disorder and schizophrenia.

Authors:  Alyson Zwicker; Vladislav Drobinin; Lynn E MacKenzie; Emily Howes Vallis; Victoria C Patterson; Jill Cumby; Lukas Propper; Sabina Abidi; Alexa Bagnell; Barbara Pavlova; Martin Alda; Rudolf Uher
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-06-06       Impact factor: 4.785

2.  Where there's smoke, there's fire: Cannabis, P2RX7 and inflammatory pathways intersect to increase psychosis susceptibility.

Authors:  David R Goldsmith
Journal:  Brain Behav Immun       Date:  2020-07-03       Impact factor: 7.217

3.  The Role of Genetics in Bipolar Disorder.

Authors:  Chiara Fabbri
Journal:  Curr Top Behav Neurosci       Date:  2021

4.  Familial and socioeconomic contributions to premorbid functioning in psychosis: Impact on age at onset and treatment response.

Authors:  Alex Hatzimanolis; Pentagiotissa Stefanatou; Emmanouil Kattoulas; Irene Ralli; Stefanos Dimitrakopoulos; Stefania Foteli; Ioannis Kosteletos; Leonidas Mantonakis; Mirjana Selakovic; Rigas-Filippos Soldatos; Ilias Vlachos; Lida-Alkisti Xenaki; Nikolaos Smyrnis; Nicholas C Stefanis
Journal:  Eur Psychiatry       Date:  2020-04-29       Impact factor: 5.361

5.  Gene-Environment Interactions in Major Mental Disorders in the Czech Republic.

Authors:  Klara Latalova; Omar Sery; Kristyna Hosakova; Ladislav Hosak
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-06       Impact factor: 2.570

6.  Association between ADORA2A gene polymorphisms and schizophrenia in the North Chinese Han population.

Authors:  Junxiao Miao; Lu Liu; Ci Yan; Xiaotong Zhu; Mengqi Fan; Peitong Yu; Keming Ji; Yinglin Huang; Yuan Wang; Gang Zhu
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-28       Impact factor: 2.570

7.  Evidence for Decreased Density of Calretinin-Immunopositive Neurons in the Caudate Nucleus in Patients With Schizophrenia.

Authors:  Istvan Adorjan; Bin Sun; Virginia Feher; Teadora Tyler; Daniel Veres; Steven A Chance; Francis G Szele
Journal:  Front Neuroanat       Date:  2020-11-13       Impact factor: 3.856

8.  Experimentally exploring the potential behavioral effects of personalized genetic information about marijuana and schizophrenia risk.

Authors:  Matthew S Lebowitz; Paul S Appelbaum; Lisa B Dixon; Ragy R Girgis; Melanie M Wall
Journal:  J Psychiatr Res       Date:  2021-05-27       Impact factor: 5.250

9.  Association between polymorphisms in the GRIN1 gene 5' regulatory region and schizophrenia in a northern Han Chinese population and haplotype effects on protein expression in vitro.

Authors:  Yong-Ping Liu; Mei Ding; Xi-Cen Zhang; Yi Liu; Jin-Feng Xuan; Jia-Xin Xing; Xi Xia; Jun Yao; Bao-Jie Wang
Journal:  BMC Med Genet       Date:  2019-01-31       Impact factor: 2.103

Review 10.  Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis.

Authors:  Meike Heurich; Melanie Föcking; David Mongan; Gerard Cagney; David R Cotter
Journal:  Mol Psychiatry       Date:  2021-07-05       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.